13h
Zacks Investment Research on MSNAtara Biotherapeutics (ATRA) Moves to Buy: Rationale Behind the UpgradeAtara Biotherapeutics (ATRA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...
Stifel Nicolaus analyst Benjamin Burnett maintained a Hold rating on Atara Biotherapeutics (ATRA – Research Report) yesterday and set a price ...
TD Cowen analyst Phil Nadeau maintained a Buy rating on Atara Biotherapeutics (ATRA – Research Report) yesterday. The company’s shares closed ...
We still need something that gives us the ability to advise our clients of the likely outcome at trial,” said Swift Currie McGhee & Hiers litigator Bill Casey.
6d
Zacks.com on MSNAtara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue EstimatesAtara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 68.85% and 150.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
Hosted on MSN1mon
Airbus’ A320 ATRA with Eurofighter nose completes first flightAirbus has revealed the completion of 'first flight' for German Aerospace Center's (DLR) modified Airbus A320 advanced technology research aircraft (ATRA) for the E-Scan radar project. This ...
Las Vegas ranked 10th in media markets with the highest spending on legal services advertising and 8th in media markets with ...
Plaintiffs lawyers seem to steer personal injury cases to the Philadelphia Common Pleas Court, and corporate defendants ...
The American Tort Reform Association (ATRA) praised South Carolina Governor Henry McMaster following a press conference on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results